I can see the logic in your argument that when there's reliable revenue, WBT could be viewed as a "buy-and-hold" stock, but as a trading stock right now. However, I experienced the exact opposite when investing in another tech stock in 2020 - TNT in cyber security. I bought a big chunk when the SP was near long-term lows (~6c), then held on tightly as a "long-term" investment. Within 6 months the SP went up >500% , and history has shown (and the charts) TNT then became a trading stock, despite having an annual revenue of ~$200m. I eventually abandoned my hope of a long-term investment and sold the lot when it had fallen back to just 300% up. But very happy, it was one of my best recent investments. Despite the large revenues, TNT consistently failed to generate positive cash flows, so the whole thing started to go pear shaped. I think it pays to remain flexible with investment decisions. Right now, I see the risk/reward to make money from having a position in WBT is very, very favourable, it's not the time to be a fence sitter.
All IMHO, DYOR
- Forums
- ASX - By Stock
- WBT
- Charts
Charts, page-4634
-
- There are more pages in this discussion • 356 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.38 |
Change
0.160(7.21%) |
Mkt cap ! $451.9M |
Open | High | Low | Value | Volume |
$2.25 | $2.38 | $2.19 | $1.896M | 828.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1096 | $2.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.38 | 105071 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1096 | 2.360 |
4 | 10851 | 2.350 |
2 | 644 | 2.330 |
2 | 1500 | 2.320 |
2 | 45062 | 2.300 |
Price($) | Vol. | No. |
---|---|---|
2.380 | 45071 | 1 |
2.390 | 10009 | 1 |
2.400 | 41577 | 5 |
2.440 | 650 | 1 |
2.450 | 5000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
WBT (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online